Position in ALEC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,811,894
+$771,636 QoQ
Shares Held
1,307,858
0.0% QoQ
Ownership
1.18%
of shares outstanding
% of Portfolio
9.57%
of 13F equity value
Holder Rank
#21
of 137 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALEC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Euclidean Capital LLC holds $29,386,023 across 6 Biotechnology names. ALEC ranks #4 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ORIC |
Oric Pharmaceuticals, Inc.
|
989,410 | $12,535,824 | |
| 2 | FHTX |
Foghorn Therapeutics Inc.
|
1,573,761 | $7,522,577 | |
| 3 | PMVP |
PMV Pharmaceuticals, Inc.
|
2,627,643 | $3,258,277 | |
| 4 | ALEC |
Alector, Inc.
This page
|
1,307,858 | $2,811,894 | |
| 5 | SRZN |
Surrozen, Inc./DE
|
87,696 | $2,554,584 | |
| 6 | TNYA |
Tenaya Therapeutics, Inc.
|
1,015,705 | $702,867 |
All Filings in ALEC
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,811,894 | 1,307,858 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,040,258 | 1,307,858 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,871,259 | 1,307,858 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,831,001 | 1,307,858 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,608,665 | 1,307,858 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,471,851 | 1,307,858 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,094,618 | 1,307,858 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,937,675 | 1,307,858 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,873,305 | 1,307,858 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $10,436,706 | 1,307,858 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,474,919 | 1,307,858 | Shares | Sole | 2023-12-01 | |
| 2023-06-30 | $5,895,172 | 980,894 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,071,733 | 980,894 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,053,651 | 980,894 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $9,279,257 | 980,894 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,965,883 | 980,894 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $13,977,739 | 980,894 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $20,255,461 | 980,894 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $22,384,001 | 980,894 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $20,432,022 | 980,894 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $19,755,205 | 980,894 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $14,840,926 | 980,894 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||